Results of a retrospective analysis involving public and private health plan members receiving medications for opioid use disorder (MOUD) suggest dangerous consequences for patients whose insurance coverage gets disrupted. Individuals experiencing disenrollment from coverage had a fourfold increased risk of all‐cause and overdose‐related death.
Gary Enos (Fri,) studied this question.